Delivery Order SPE2DB20D1050-SPE2DB25FH71C

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The contract has a ceiling value of $2,125.04 and is a firm fixed price delivery order with a completion date of May 30, 2025. The contract is not set-aside and is an open competition award. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, a vaccine product. The contract has a ceiling value of $1,222.33 and runs through March 5, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The firm-fixed-price contract, valued at $4,950.60, has a performance period through May 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.72 firm fixed-price delivery order is for the supply of TRUMENBA 120 MCG/0.5 ML VACCINE 0.5ML, a vaccine product. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $2,495.82 firm fixed-price delivery order is for the provision of 4564957210 - TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml doses. The firm-fixed-price delivery order has a ceiling value of $2,887.80 and an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
This federal contract award, valued at $4,250.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 mcg/0.5 ml Trumenba vaccine, with a performance period extending through May 7, 2025. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program and represents an open competition....
This federal contract award is for the delivery of Trumenba 120 mcg/0.5 ml vaccine to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,064.76 and a completion date of December 6, 2023. This award is a delivery order issued under an Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,092.04 firm fixed-price delivery order is for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, with a performance period through August 12, 2024. The award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,269.76 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on July 31, 2024, with an ultimate completion date of August 1, 2024. The contract is for the delivery of 4565399768 - TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC)...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB25FH71C
    Delivery Order

This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The contract has a ceiling value of $1,062.52 and is a Firm Fixed Price type contract. The place of performance is Conshohocken, Pennsylvania. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/3/25, 9:43 AM